Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05220748
Title RM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced CuSCC and HNSCC
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rakuten Medical, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries


No variant requirements are available.